BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16363599)

  • 21. Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori.
    Groisman GM; George J; Berman D; Harpaz N
    Am J Gastroenterol; 1994 Sep; 89(9):1548-51. PubMed ID: 8079936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori.
    Wang M; Furuta T; Takashima M; Futami H; Shirai N; Hanai H; Kaneko E
    J Gastroenterol; 1999; 34 Suppl 11():10-7. PubMed ID: 10616759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of H. pylori infection in the pathophysiology of duodenal ulcer disease.
    McColl KE; el-Omar EM; Gillen D
    J Physiol Pharmacol; 1997 Sep; 48(3):287-95. PubMed ID: 9376611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children.
    Kato S; Ozawa K; Koike T; Sekine H; Ohara S; Minoura T; Iinuma K
    Helicobacter; 2004 Apr; 9(2):100-5. PubMed ID: 15068410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Case of Menétrier's disease with gastric hypersecretion of acid (H+)].
    Ohkusa T; Yamaoka M; Nakano F; Sakamoto Y; Mitsunaga K; Miyazaki R; Momoi H
    Nihon Naika Gakkai Zasshi; 1982 Nov; 71(11):1581-5. PubMed ID: 7166675
    [No Abstract]   [Full Text] [Related]  

  • 26. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
    Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
    Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment.
    Kawasaki M; Hizawa K; Aoyagi K; Nakamura S; Fujishima M
    Am J Gastroenterol; 1997 Oct; 92(10):1909-12. PubMed ID: 9382064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resolution of Menetrier's disease after Helicobacter pylori eradication].
    Jung JH; Hong SJ; Lee MS
    Korean J Gastroenterol; 2006 Jul; 48(1):1-3. PubMed ID: 16861874
    [No Abstract]   [Full Text] [Related]  

  • 29. Helicobacter pylori gastritis of the gastric carcinoma phenotype: is histology capable of identifying high-risk gastritis?
    Stolte M; Meining A
    J Gastroenterol; 2000; 35 Suppl 12():98-101. PubMed ID: 10779227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Helicobacter pylori gastritis in gastric atrophy, intestinal metaplasia, and gastric neoplasia.
    Smith VC; Genta RM
    Microsc Res Tech; 2000 Mar; 48(6):313-20. PubMed ID: 10738312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 polymorphisms associated with increased risk of gastric cancer.
    El-Omar EM; Carrington M; Chow WH; McColl KE; Bream JH; Young HA; Herrera J; Lissowska J; Yuan CC; Rothman N; Lanyon G; Martin M; Fraumeni JF; Rabkin CS
    Nature; 2000 Mar; 404(6776):398-402. PubMed ID: 10746728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiopathology of Helicobacter pylori infection: Pepsinogen secretion].
    Urita Y; Miki K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():235-9. PubMed ID: 11979784
    [No Abstract]   [Full Text] [Related]  

  • 33. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulated gastrinemia and maximal acid output in Helicobacter pylori-positive patients.
    Testins G
    Hepatogastroenterology; 2002; 49(48):2 p preceding table of contents. PubMed ID: 12647696
    [No Abstract]   [Full Text] [Related]  

  • 35. Resolution of gastrointestinal protein loss after Helicobacter pylori eradication in a patient with hypertrophic lymphocytic gastritis.
    Madisch A; Aust D; Morgner A; Grossmann D; Schmelz R; Kropp J; Ehninger G; Baretton G; Miehlke S
    Helicobacter; 2004 Dec; 9(6):629-31. PubMed ID: 15610076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible protein-losing hypertrophic gastropathy: causal relationship with Helicobacter pylori infection, or simple coincidence?
    Simon L; Fehér I; Salamon A; Vadász E
    Am J Gastroenterol; 2000 Apr; 95(4):1091-2. PubMed ID: 10763972
    [No Abstract]   [Full Text] [Related]  

  • 37. [Helicobacter pylori and gastric cancer].
    Tanida N; Sakagami T; Nakamura Y; Kawaura A; Hikasa Y; Shimoyama T
    Nihon Geka Gakkai Zasshi; 1996 Apr; 97(4):257-62. PubMed ID: 8692140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
    Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
    Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric cancer--a long-term consequence of Helicobacter pylori infection?
    Sipponen P
    Scand J Gastroenterol Suppl; 1994; 201():24-7. PubMed ID: 8047820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers.
    Sipponen P; Graham DY
    Scand J Gastroenterol; 2007 Jan; 42(1):2-10. PubMed ID: 17190755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.